NCT06650748 2026-03-17
NeoMARS
Peking University
Phase 2 Enrolling by invitation
Clinical Trials
6 trialsNCT07275463 2025-12-22
[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase 2 Enrolling by invitation
NCT07292571 2025-12-18
Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase 2 Enrolling by invitation
NCT06680596 2025-09-22
SAFIR3LibHERty
UNICANCER
Phase 2 Enrolling by invitation
NCT06958445 2025-05-06
SAFE
Taipei City Hospital
Phase 2 Enrolling by invitation
NCT05396118 2024-05-14
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Rigshospitalet, Denmark
Phase 2 Enrolling by invitation